Clinical Trial Update: Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PQ Grass for grass pollen–induced seasonal allergic rhinitis and rhinoconjunctivitis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinoconjunctivitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• PQ Grass

Snippet

Sponsor: Allergy Therapeutics | Conditions: Seasonal Allergic Rhinitis, Rhinoconjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2025-04-02